Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1α-Hydroxylase in the Classical and Nonclassical Actions of 1α,25-Dihydroxyvitamin D3

Seminars in Dialysis

Volumn 20, Issue 4, 2007, Pages 316-324

  Jones, Glenville ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D;

ANIMAL; ARTICLE; CHEMISTRY; CHRONIC KIDNEY FAILURE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; CALCITRIOL; GENE EXPRESSION REGULATION; HUMANS; KIDNEY FAILURE, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 34547208630     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00302.x     Document Type: Article

References (70)

1. Holick MF : Chapter 3: Photobiology of vitamin D. In : Feldman D, Pike JW, Glorieux FH (eds). Vitamin D, 2nd Edition. New York : Elsevier Academic Press, 2005 : 37 46
2. Jones G, Strugnell SA, DeLuca HF : Current understanding of the molecular actions of vitamin D. Physiol Rev 78 : 1193 1231, 1998
3. Prosser DE, Jones G : Enzymes involved in the activation and inactivation of vitamin D. Trends in Biochem Sci 29 : 664 673, 2004
4. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW : Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101 : 7711 7715, 2004
5. Jones G, Byford V, West S, Masuda S, Ibrahim G, Kaufmann M, Knutson J, Strugnell S, Mehta R : Hepatic activation & inactivation of clinically-relevant vitamin D analogs and prodrugs. Anticancer Res 26 : 2589 2596, 2006
6. Hollis BW : Chapter 58: Detection of vitamin D and its major metabolites. In : Feldman D, Pike JW, Glorieux FH (eds). Vitamin D, 2nd Edition. New York : Elsevier Academic Press, 2005 : 931 950
7. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, Cooke NE : Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103 : 239 251, 1999
8. Willnow TE, Nykjaer A : Chapter 10: Endocytic pathways for 25-hydroxyvitamin D3. In : Feldman D, Pike JW, Glorieux FH (eds). Vitamin D, 2nd Edition. New York : Elsevier Academic Press, 2005 : 153 163
9. Martinez I, Saracho R, Montenegro J, Llach F : A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant 11 : 22 28, 1996
10. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH : The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12 : 1552 1559, 1997
11. Yamamoto K, Uchida E, Urushino N, Sakaki T, Kagawa N, Sawada N, Kamakura M, Kato S, Inouye K, Yamada S : Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1. J Biol Chem 280 : 30511 30516, 2005
12. Armbrecht HJ, Hodam TL, Boltz MA : Hormonal regulation of 25-hydroxyvitamin D3-1α-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. Arch Biochem Biophys 409 : 298 304, 2003
13. Quarles LD : FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285 : E1 E9, 2003
14. Fraser D, Kooh SW, Kind P, Holick MF, Tanaka Y, DeLuca HF : Pathogenesis of hereditary vitamin D dependency rickets. N Engl J Med 289 : 817 822, 1973
15. Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R : Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142 : 3135 3141, 2001
16. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D : Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279 : 16754 16766, 2004
17. Holick MF, Schnoes HK, DeLuca HF, Gray RW, Boyle IT, Suda T : Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry 11 : 4251 4255, 1972
18. Holick MF, Kleiner-Bossaller A, Schnoes HK, Kasten PM, Boyle IT, DeLuca HF : 1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. J Biol Chem 248 : 6691 6696, 1973
19. Ohyama Y, Okuda K : Isolation and characterization of a cytochrome P-450 from rat kidney mitochondria that catalyzes the 24-hydroxylation of 25-hydroxyvitamin D3. J Biol Chem 266 : 8690 8695, 1991
20. Tenenhouse HS, Yip A, Jones G : Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets. J Clin Invest 81 : 461 465, 1988
21. Jones G, Vriezen D, Lohnes D, Palda V, Edwards NS : Side-chain hydroxylation of vitamin D3 and its physiological implications. Steroids 49 : 29 53, 1987
22. Makin G, Lohnes D, Byford V, Ray R, Jones G : Target cell metabolism of 1,25-(OH)2D3 to calcitroic acid: evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262 : 173 180, 1989
23. Reddy GS, Tserng KY : Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 28 : 1763 1769, 1989
24. Shinki T, Jin CH, Nishimura A, Nagai Y, Ohyama Y, Noshiro M, Okuda K, Suda T : Parathyroid hormone inhibits 25-hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1α,25-dihydroxyvitamin D3 in rat kidney but not in intestine. J Biol Chem 267 : 13757 13762, 1992
25. Lohnes D, Jones G : Further metabolism of 1,25-dihydroxyvitamin D3 in target cells. J Nutr Sci Vitaminol (Tokyo) Spec No : 75 78, 1992
26. St-Arnaud R : Targeted inactivation of vitamin D hydroxylases in mice. Bone 25 : 27 29, 1999
27. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH : Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141 : 2658 2666, 2000
28. Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G : Altered Pharmacokinetics of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) null mouse. Endocrinology 146 : 825 834, 2005
29. Esvelt RP, Schnoes HK, DeLuca HF : Isolation and characterization of 1α-hydroxy-23-carboxy-tetranorvitamin D: a major metabolite of 1,25-dihydroxyvitamin D3. Biochemistry 18 : 3977 3983, 1979
30. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW : The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13 : 325 349, 1998
31. Whitfield GK, Jurutka PW, Haussler CA, Hsieh J-C, Barthel TK, Jacobs ET, Dominguez CE, Thatcher ML, Haussler MR : Chapter 13: Nuclear receptor: structure-function, molecular control of gene transcription and novel bioactions. In : Feldman D, Pike JW, Glorieux FH (eds). Vitamin D, 2nd Edition. New York : Elsevier Academic Press, 2005 : 219 262
32. Stumpf WE : Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting. Histochem Cell Biol 104 : 417 427, 1995
33. Pike JW : Vitamin D3 receptors: structure and function in transcription. Annu Rev Nutr 11 : 189 216, 1991
34. White JH : Profiling 1,25-dihydroxyvitamin D3-regulated gene expression by microarray analysis. J Steroid Biochem Mol Biol 89-90 : 239 244, 2004
35. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S : Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16 : 391 396, 1997
36. Holick MF : Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr 80 (Suppl. 1678S 1688S, 2004
37. Goodman WG, Coburn JW : The use of 1,25-dihydroxyvitamin D3 in early renal failure. Annu Rev Med 43 : 227 237, 1992
38. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ : Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74 : 2136 2143, 1984
39. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo Jr. CA, Thadhani R : Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16 : 1115 1125, 2005
40. KDOQI : Clinical practise guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (Suppl. 3 S1 S202, 2003
41. Grant WB, Garland CF : A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 48 : 115 123, 2004
42. Grant WB, Garland CF : Evidence supporting the role of vitamin D in reducing the risk of cancer. J Intern Med 252 : 178 179, 2002
43. Schwartz GG, Hulka BS : Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10 : 1307 1311, 1990
44. Bikle DD, Chang S, Crumrine D, Elalieh H, Man MQ, Choi EH, Dardenne O, Xie Z, St-Arnaud R, Feingold K, Elias PM : 25-Hydroxyvitamin D-1α-hydroxylase required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 122 : 984 992, 2004
45. Bises G, Kallay E, Weiland T, Wrba F, Wenzl E, Bonner E, Kriwanek S, Obrist P, Cross HS : 25-hydroxyvitamin D3-1α-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52 : 985 989, 2004
46. Jones G, Ramshaw H, Zhang A, Cook R, Byford V, White J, Petkovich M : Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1α / CYP24) in human non-small cell lung carcinomas. Endocrinology 140 : 3303 3310, 1999
47. Hollis BW, Iskersky VN, Chang MK : In vitro metabolism of 25-hydroxyvitamin D3 by human trophoblastic homogenates, mitochondria, and microsomes: lack of evidence for the presence of 25-hydroxyvitamin D3-1 alpha- and 24R-hydroxylases. Endocrinology 125 : 1224 1230, 1989
48. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL : Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305 : 440 443, 1981
49. Lambert PW, Stern PH, Avioli RC, Brackett NC, Turner RT, Greene A, Fu IY, Bell NH : Evidence for extrarenal production of 1 alpha,25-dihydroxyvitamin D in man. J Clin Invest 69 : 722 725, 1982
50. Shultz TD, Fox J, Heath III. H, Kumar R : Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A re-examination Proc Natl Acad Sci USA 80 : 1746 1750, 1983
51. Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E : Extra-renal production of calcitriol in chronic renal failure. Kidney Int 34 : 368 375, 1988
52. Dusso AS, Finch J, Brown A, Ritter C, Delmez J, Schreiner G, Slatopolsky E : Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 72 : 157 164, 1991
53. Adams JS, Gacad MA, Singer FR, Sharma OP : Production of 1,25-dihydroxyvitamin D3 by pulmonary alveolar macrophages from patients with sarcoidosis. Ann NY Acad Sci 465 : 587 594, 1986
54. Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E : Γ-Interferon-induced resistance to 1,25-(OH)2D3 in human monocytes & macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 82 : 2222 2232, 1997
55. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C : Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 21 : 37 47, 2006 [Epub Sep 19, 2005]
56. Hewison M, Adams JS : Chapter 79: Extra-renal 1α-hydroxylase activity and human disease. In : Feldman D, Pike JW, Glorieux FH (eds). Vitamin D, 2nd Edition. New York : Elsevier Academic Press, 2005 : 1379 1402
57. Hollis BW : Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135 : 317 322, 2005
58. Vieth R : Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90 : 575 579, 2004
59. Jongen MJ, van der Vijgh WJ, Lips P, Netelenbos JC : Measurement of vitamin D metabolites in anephric subjects. Nephron 36 : 230 234, 1984
60. Vieth R, El-Hajj Fuleihan G : There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase. J Endocrinol Invest 28 : 183 186, 2005
61. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B : Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116 : 634 639, 2004
62. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B : Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 80 : 752 758, 2004
63. Lambert PW, De Oreo PB, Fu IY, Kaetzel DM, von Ahn K, Hollis BW, Roos BA : Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome. Metab Bone Dis Relat Res 4 : 7 15, 1982
64. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ : Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24 : 503 510, 2004
65. Canadian Dermatological Society and Canadian Cancer Society, Press Release : Key Findings from UV, Vitamin D and Health Conference : National Health Groups Recognize Benefits of Vitamin D : Available at http://www.dermatology.ca/media/news : Toronto, 25 May 2006
66. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R : Estimates of optimal vitamin D status. Osteoporos Int 16 : 713 716, 2005
67. Lim HW, Gilchrest BA, Cooper KD, Bischoff-Ferrari HA, Rigel DS, Cyr WH, Miller S, DeLeo VA, Lee TK, Demko CA, Weinstock MA, Young A, Edwards LS, Johnson TM, Stone SP : Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol 52 : 868 876, 2005
68. Sorensen OH, Lund B, Thode JD, Storm TL, Lund B, Brahm M, Friedberg M, Holmegaard SN : Effect of sunlight exposure on circulating 1,25-dihydroxyvitamin D in hemodialyzed patients and of exogenous parathyroid hormone in anephric patients. Acta Med Scand 219 : 215 219, 1986
69. Heaney RP : The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97 : 13 19, 2005
70. Armas LA, Hollis BW, Heaney RP : Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89 : 5387 5391, 2004